Wednesday, November 28, 2018 9:11:25 AM
November 25, 2018
https://cen.acs.org/energy/biofuels/fulfill-biofuelspromise-scientists-boost-plant/96/i47
...
To Peoples, the future looks promising. A 20% increase in the yield of conventional oil crops like canola and soybean could boost the economic value of these crops by $10 billion, he says. If the current techniques work well in camelina, the company will attempt similar gene edits in canola and soybeans.
Although Yield10’s primary goal is to sell its camelina oil for human health products and as an ingredient for agricultural animal feed rather than as a feedstock for biofuels, Peoples says the gene-editing discovery made by Yield10 could be beneficial for that type of application too.
Yield10 won’t disclose the exact edits its scientists made to improve camelina’s oil production, citing proprietary information. But presentation slides shared online on Nov. 4 for investors indicate that edits to genes that the firm calls C3008a, C3008b, and C3009 work to increase oil production by simultaneously increasing fatty acid biosynthesis and blocking the metabolism of the synthesized lipid.
At the same time, Yield10’s Canadian subsidiary, Metabolix Oilseeds, is working to edit a gene the company has called C3007 in camelina and canola. Gene C3007 encodes a protein that negatively regulates a key enzyme in fatty acid biosynthesis, acetyl-CoA carboxylase. By decreasing the activity of this negative regulator, the firm aims to boost the enzyme’s activity and make more plant oil.
...
Recent YTEN News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 09:15:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 07:15:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 12:11:23 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 12:10:36 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/20/2024 12:09:48 AM
- Yield10 Bioscience Announces Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/14/2024 08:37:26 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 07/29/2024 08:01:34 PM
- Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets • GlobeNewswire Inc. • 07/17/2024 10:45:00 PM
- Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets • GlobeNewswire Inc. • 07/17/2024 12:30:39 PM
- Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina • GlobeNewswire Inc. • 06/17/2024 12:32:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 08:31:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/10/2024 08:09:03 PM
- Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label • GlobeNewswire Inc. • 05/23/2024 12:32:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:03:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:01:57 PM
- Yield10 Bioscience Announces First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/15/2024 08:00:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 12:48:23 PM
- Yield10 Bioscience Announces Delisting from Nasdaq • GlobeNewswire Inc. • 05/15/2024 12:30:21 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 05/09/2024 03:15:37 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/07/2024 08:01:17 PM
- Yield10 Bioscience Announces 1-for-24 Reverse Stock Split • GlobeNewswire Inc. • 05/01/2024 12:30:00 PM
- Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 04/01/2024 08:01:07 PM
- Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024 • GlobeNewswire Inc. • 03/28/2024 08:01:20 PM
- Yield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canada • GlobeNewswire Inc. • 03/26/2024 12:29:24 PM
- USDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the United States • GlobeNewswire Inc. • 03/21/2024 12:29:14 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM